Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Sci Rep ; 11(1): 14636, 2021 07 19.
Article in English | MEDLINE | ID: mdl-34282208

ABSTRACT

Finding effective and objective biomarkers to inform the diagnosis of schizophrenia is of great importance yet remains challenging. Relatively little work has been conducted on multi-biological data for the diagnosis of schizophrenia. In this cross-sectional study, we extracted multiple features from three types of biological data, including gut microbiota data, blood data, and electroencephalogram data. Then, an integrated framework of machine learning consisting of five classifiers, three feature selection algorithms, and four cross validation methods was used to discriminate patients with schizophrenia from healthy controls. Our results show that the support vector machine classifier without feature selection using the input features of multi-biological data achieved the best performance, with an accuracy of 91.7% and an AUC of 96.5% (p < 0.05). These results indicate that multi-biological data showed better discriminative capacity for patients with schizophrenia than single biological data. The top 5% discriminative features selected from the optimal model include the gut microbiota features (Lactobacillus, Haemophilus, and Prevotella), the blood features (superoxide dismutase level, monocyte-lymphocyte ratio, and neutrophil count), and the electroencephalogram features (nodal local efficiency, nodal efficiency, and nodal shortest path length in the temporal and frontal-parietal brain areas). The proposed integrated framework may be helpful for understanding the pathophysiology of schizophrenia and developing biomarkers for schizophrenia using multi-biological data.


Subject(s)
Algorithms , Biomarkers/analysis , Schizophrenia/diagnosis , Adult , Biomarkers/blood , Biomarkers/metabolism , Blood Cell Count , Blood Chemical Analysis/statistics & numerical data , Case-Control Studies , China/epidemiology , Cross-Sectional Studies , Databases, Factual/statistics & numerical data , Diagnosis, Differential , Discriminant Analysis , Electroencephalography/statistics & numerical data , Feces/chemistry , Female , Gastrointestinal Microbiome/physiology , Humans , Machine Learning , Male , Middle Aged , Predictive Value of Tests , Schizophrenia/epidemiology , Schizophrenia/etiology
2.
Neuroscience ; 460: 1-12, 2021 04 15.
Article in English | MEDLINE | ID: mdl-33588002

ABSTRACT

Emerging evidence suggests that the coupling relating the structural connectivity (SC) of the brain to its functional connectivity (FC) exhibits remarkable changes during development, normal aging, and diseases. Although altered structural-functional connectivity couplings (SC-FC couplings) have been previously reported in schizophrenia patients, the alterations in SC-FC couplings of different illness stages of schizophrenia (SZ) remain largely unknown. In this study, we collected structural and resting-state functional MRI data from 73 normal controls (NCs), 61 first-episode (FeSZ) and 78 chronic (CSZ) schizophrenia patients. Positive and negative syndrome scale (PANSS) scores were assessed for all patients. Structural and functional brain networks were constructed using gray matter volume (GMV) and resting-state magnetic resonance imaging (rs-fMRI) time series measurements. At the connectivity level, the CSZ patients showed significantly increased SC-FC coupling strength compared with the FeSZ patients. At the node strength level, significant decreased SC-FC coupling strength was observed in the FeSZ patients compared to that of the NCs, and the coupling strength was positively correlated with negative PANSS scores. These results demonstrated divergent alterations of SC-FC couplings in FeSZ and CSZ patients. Our findings provide new insight into the neuropathological mechanisms underlying the developmental course of SZ.


Subject(s)
Schizophrenia , Brain/diagnostic imaging , Brain Mapping , Gray Matter/diagnostic imaging , Humans , Magnetic Resonance Imaging , Neural Pathways/diagnostic imaging , Schizophrenia/diagnostic imaging
SELECTION OF CITATIONS
SEARCH DETAIL